Biernasiuk Anna, Banasiewicz Anna, Masłyk Maciej, Martyna Aleksandra, Janeczko Monika, Baranowska-Łączkowska Angelika, Malm Anna, Łączkowski Krzysztof Z
Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Medical University of Lublin, Chodźki 1, 20-093 Lublin, Poland.
Department of Chemical Technology and Pharmaceuticals, Faculty of Pharmacy, Collegium Medicum, Nicolaus Copernicus University, Jurasza 2, 85-089 Bydgoszcz, Poland.
Materials (Basel). 2021 Jun 23;14(13):3500. doi: 10.3390/ma14133500.
There is a need to search for new antifungals, especially for the treatment of the invasive infections, caused mainly by . These infections are steadily increasing at an alarming rate, mostly among immunocompromised patients. The newly synthesized compounds (-) were characterized by physicochemical parameters and investigated for antimicrobial activity using the microdilution broth method to estimate minimal inhibitory concentration (MIC). Additionally, their antibiofilm activity and mode of action together with the effect on the membrane permeability in were investigated. Biofilm biomass and its metabolic activity were quantitatively measured using crystal violet (CV) staining and tetrazolium salt (XTT) reduction assay. The cytotoxic effect on normal human lung fibroblasts and haemolytic effect were also evaluated. The results showed differential activity of the compounds against yeasts (MIC = 0.24-500 µg/mL) and bacteria (MIC = 125-1000 µg/mL). Most compounds possessed strong antifungal activity (MIC = 0.24-7.81 µg/mL). The compounds , and , showed no inhibitory (at 1/2 × MIC) and eradication (at 8 × MIC) effect on biofilm. Only slight decrease in the biofilm metabolic activity was observed for compound . Moreover, the studied compounds increased the permeability of the membrane/cell wall of and their mode of action may be related to action within the fungal cell wall structure and/or within the cell membrane. It is worth noting that the compounds had no cytotoxicity effect on pulmonary fibroblasts and erythrocytes at concentrations showing anticandidal activity. The present studies in vitro confirm that these derivatives appear to be a very promising group of antifungals for further preclinical studies.
需要寻找新的抗真菌药物,尤其是用于治疗主要由……引起的侵袭性感染。这些感染正以惊人的速度稳步增加,主要发生在免疫功能低下的患者中。新合成的化合物(-)通过理化参数进行表征,并使用微量稀释肉汤法研究其抗菌活性以估计最低抑菌浓度(MIC)。此外,还研究了它们的抗生物膜活性、作用方式以及对……膜通透性的影响。使用结晶紫(CV)染色和四氮唑盐(XTT)还原试验对生物膜生物量及其代谢活性进行定量测量。还评估了对正常人肺成纤维细胞的细胞毒性作用和溶血作用。结果表明这些化合物对酵母(MIC = 0.24 - 500 µg/mL)和细菌(MIC = 125 - 1000 µg/mL)具有不同的活性。大多数化合物具有较强的抗真菌活性(MIC = 0.24 - 7.81 µg/mL)。化合物……、……和……对……生物膜没有抑制(在1/2×MIC时)和根除(在8×MIC时)作用。仅观察到化合物……使生物膜代谢活性略有下降。此外,所研究的化合物增加了……膜/细胞壁的通透性,其作用方式可能与在真菌细胞壁结构内和/或细胞膜内的作用有关。值得注意的是,在显示抗念珠菌活性的浓度下,这些化合物对肺成纤维细胞和红细胞没有细胞毒性作用。目前的体外研究证实,这些衍生物似乎是非常有前途的抗真菌药物组,可用于进一步的临床前研究。